Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1883Lung Neoplasms 1308Small Cell Lung Carcinoma 329Colorectal Neoplasms 271Breast Neoplasms 243Melanoma 221Neoplasms 218Ovarian Neoplasms 193Neoplasm Metastasis 181Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 152Stomach Neoplasms 143Head and Neck Neoplasms 120Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 111Esophageal Neoplasms 109Prostatic Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 97Urinary Bladder Neoplasms 89Mesothelioma 88Colonic Neoplasms 86Mesothelioma, Malignant 81Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 64Disease 63Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Liver Neoplasms 49

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Thoracic × 1 year × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡